Literature DB >> 3755581

Oral administration of active vitamin D metabolites to low birthweight infants.

I Z Kovar, P D Mayne, J J James, I C Barnes.   

Abstract

The active vitamin D metabolites 1 alpha, 25-dihydroxycholecalciferol (Rocaltrol) and the analogue 1 alpha-hydroxycholecalciferol (One-Alpha) are adequately absorbed after oral administration in the preterm infant. The absorption pattern is similar to that seen in adults.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3755581      PMCID： PMC1777921          DOI： 10.1136/adc.61.8.795

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  6 in total

1.  An improved competitive protein binding assay for 1,25-dihydroxyvitamin D.

Authors:  J P Mallon; J G Hamilton; C Nauss-Karol; R J Karol; C J Ashley; D S Matuszewski; C A Tratnyek; G F Bryce; O N Miller
Journal:  Arch Biochem Biophys       Date:  1980-04-15       Impact factor: 4.013

2.  Plasma active vitamin D concentration in low birthweight infants with rickets and its response to vitamin D treatment.

Authors:  Y Seino; T Ishii; T Shimotsuji; M Ishida; H Yabuuchi
Journal:  Arch Dis Child       Date:  1981-08       Impact factor: 3.791

3.  Neonatal rickets in one of identical twins.

Authors:  I Z Kovar; P Mayne; J Wallis
Journal:  Arch Dis Child       Date:  1982-10       Impact factor: 3.791

4.  Metabolic bone disease in preterm infants.

Authors:  O G Brooke; A Lucas
Journal:  Arch Dis Child       Date:  1985-07       Impact factor: 3.791

5.  Blood concentrations of dihydroxylated vitamin D metabolites after an oral dose.

Authors:  R S Mason; D Lissner; S Posen; A W Norman
Journal:  Br Med J       Date:  1980-02-16

6.  Response of neonatal hypocalcaemia to 1 alpha-hydroxyvitamin D3.

Authors:  Y Barak; B Milbauer; Y Weisman; S Edelstein; Z Spirer
Journal:  Arch Dis Child       Date:  1979-08       Impact factor: 3.791
  6 in total
  1 in total

1.  Hypothyroidism and unusual rickets in a very preterm infant.

Authors:  P Macmahon; M Blair; I Kovar
Journal:  Postgrad Med J       Date:  1989-05       Impact factor: 2.401
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.